Patrick Trucchio
Stock Analyst at HC Wainwright & Co.
(0)
# 4475
Out of 5,332 analysts
415
Total ratings
26.20%
Success rate
-14.94%
Average return
Main Sectors:
Top Industries:
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
QURE uniQure | Reiterates: Buy | 70 70 | 15.89 | 340.53% | 14 | Apr 21, 2025 | |
VYGR Voyager Therapeutics | Reiterates: Buy | 30 30 | 3.49 | 759.6% | 10 | Apr 8, 2025 | |
HRMY Harmony Biosciences Hldgs | Reiterates: Buy | 70 70 | 29.93 | 133.88% | 6 | Apr 8, 2025 | |
ANRO Alto Neuroscience | Initiates Coverage On: Buy | 10 | 2.33 | 329.18% | 1 | Apr 7, 2025 | |
SGMO Sangamo Therapeutics | Reiterates: Buy | 10 10 | 0.72 | 1288.89% | 25 | Apr 7, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 80 80 | 19.84 | 303.23% | 8 | Apr 7, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 12 12 | 5.42 | 121.4% | 17 | Apr 3, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 500 500 | 273.22 | 83% | 26 | Apr 2, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 25 10 | 1.32 | 657.58% | 19 | Apr 1, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 60 60 | 5.64 | 963.83% | 17 | Mar 28, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 10 10 | 0.57 | 1654.39% | 17 | Mar 26, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 10 10 | 1.47 | 580.27% | 18 | Mar 19, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 10 10 | 1.24 | 706.45% | 16 | Mar 18, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 100 100 | 30.8 | 224.68% | 20 | Mar 12, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 5 5 | 0.54 | 825.93% | 17 | Mar 10, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 55 55 | 6.56 | 738.41% | 18 | Mar 7, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 75 75 | 3.9 | 1823.08% | 23 | Mar 7, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 45 45 | 4.04 | 1013.86% | 14 | Mar 4, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 110 110 | 6.14 | 1691.53% | 23 | Feb 28, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 85 85 | 31.77 | 167.55% | 2 | Feb 19, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 190 150 | 6.43 | 2232.81% | 17 | Feb 13, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 80 80 | 14.03 | 470.21% | 22 | Feb 12, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 40 40 | 11.1 | 260.36% | 14 | Jan 27, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 80 60 | n/a | n/a | 14 | Oct 15, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 15 7 | n/a | n/a | 8 | Nov 28, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 360 | n/a | n/a | 5 | May 15, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 5 | n/a | n/a | 2 | Mar 23, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 20 | n/a | n/a | 1 | Feb 15, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 3 | n/a | n/a | 2 | Feb 7, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 5 | n/a | n/a | 1 | Oct 3, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 170 68 | 14.48 | 369.61% | 2 | Sep 23, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 35 7 | n/a | n/a | 4 | Jul 15, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 120 100 | n/a | n/a | 3 | Feb 9, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 230 20 | 0.33 | 5960.61% | 2 | Dec 28, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 500 625 | n/a | n/a | 2 | Nov 22, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 25 10 | n/a | n/a | 3 | Oct 19, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 260 340 | 273.21 | 24.45% | 1 | Aug 18, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 8 | n/a | n/a | 1 | Jul 26, 2021 |